Study of pharmacology concerned with movement of drugs within the body.
Biopharmaceutics
The study of the chemical and physical properties of drugs and the biological effects they produce.
Bioequivalence
Division of pharmacokinetics to assess the biological equivalence of two proprietary preparations of a drug.
Absolute and Relative Bioavailability
Absolute bioavailability is determined by comparing the blood (plasma) concentration-time-curves with drug usage.
Relative bioavailability is determined by comparing the plasma concentration-time-curves with different formulations of drug usage.
Bioanalytical Methods &Bioequivalence Studies
Combined platform to evaluate the analytical methods on bioequivalence.
Drug Clinical Studies
Safety and efficacy studies of the drug on human participants.
Clinical and Experimental Pharmacology
Clinical pharmacology is the study of drugs and their clinical use. Experimental pharmacology is study through experimental use in controlled situations.
Biochemistry &Pharmacology
The interlinking of biochemical processes with drugs and study the combined effect.
Pharmaceutical Research
Research analysis on everyday pharmaceutical products and studies.
Pharmaceutical Science and Research
Research analysis on developments in pharmaceutical science.
Pharmaceutical Regulatory Affairs
Governments? approach to protect public health by controlling the safety and efficacy of pharmaceutical products.
Drug BA/BE studies
Bioavailability and Bioequivalence studies of pharmaceutical drugs.
Bioequivalence and Simulation
Imitation of biological equivalence of two proprietary preparations of a drug.
Biosimilars Requirement
To deal with need of bioequivalence in the field of Pharma.
Biowaivers
Bioavailability and/or bioequivalence studies that can be waived are called biowaivers.
Bioavailability Enhancement
Enriching the studies and methods in bioavailability.
Drug Delivery Systems
Drug delivery refers to approaches for transporting a pharmaceutical compound in the body.
Drug Delivery Pathway
The means and ways for drug transport in the body.
BiosimilarsOncology
Role of biosimilars in cancer
Biosimilars-Regulatory Affairs
Governments? approach toprotect public health by controlling the safety and efficacy of biosimilars.
Biosimilars and Pharmacology
Action mechanism of biosimilars.
Drug Development Systems
Development of drug upon drug delivery tests and preparation of systems to handle the process.
Bioavailability
The proportion of a drug in body circulation to have an active effect.
Biosimilars Models
A biopharmaceutical drug designed to have active properties similar to already licensed drug.
General Bioequivalence
Study of all general aspects of bioequivalence.
Bioavailability Metrics
Methods to measure and produce statistical data in terms of advancement of bioavailability.
Journal Features
All submissions will undergo vigorous peer review process.
High quality review process.
Permanent published archives.
Author loyal benefits.
Reviewer credits.
Visible specified citations.
Open access - Maximum dissemination.
Un-interrupted author communication.
Standard author guidelines.
Minimal publication charges with convenient and safe modes of transfer.
Enliven: Biosimilars and Bioavailability aims to become one of the most popular Open access journals in the science field and to follow flawless review process with high quality articles.
Journal provides a common platform for editors, reviewers, authors, and readers to have an uninterrupted scientific communication. In order to become the leading journal, Enliven: Biosimilars and Bioavailabilityprovide wide scope which allows and accepts articles from multiple disciplines and guides the articles according to the peer review process.
Journal processes different types of articles viz. research, review, case reports, technical reports, editorials, letters, letter to editors, commentaries, short communications, conference proceedings, announcements, rapid communications, addendums, book reviews, concept papers, abstracts, graphical abstracts, discussions, errata, project report, and expression of concerns. There is no limit for the article length. Journal aim is to encourage scientists, academicians, students, and many other authors to publish their work as elaborate as they can.
SCOPE:
Enliven: Biosimilars and Bioavailability provides wide scope for the authors, readers in all possible fields. Journal emboldens authors with its rigid peer review process and journal follows stringent editorial policies to avoid all publishing discrepancies.
Enliven: Biosimilars and Bioavailability is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments and supports current and upcoming research in journal fields. It also aims to follow flawless review process with high quality articles. This journal aims to become one of the leading journals which aid scientific community in knowledge dissemination. This journal provides a huge platform for editors, reviewers, authors, and readers to have an uninterrupted scientific communication. In order to become the leading journal, Enliven: Biosimilars and Bioavailability provide wide scope which allows and accepts articles from multiple disciplines and guides the articles according to the peer review process.
Enliven: Biosimilars and Bioavailability looks forward for the diverse submissions to disseminate the information about current discoveries and developments in the journal field. Journal has unique editorial board to take care of publishing activities in organized way. Journal policies are coined to allow flexible communications among different groups of journal members and to allow the journal to follow the strict rules.
OPEN ACCESS:
Journal’s main motto is to promote open access and sustain in the open access field with new approaches and to widen the chances in open access which will create a new turn in current era.
As journal is an open access, we seek support from scientific community, industries, funding agencies, universities, institutes, and any others interested in publications.
Journal believes that scientific information must be accessible to everyone without any barriers.
Journalcharges the authors with very minimal publication charges and depends on our users those who support global commons. Journal, also has the policy of providing reliable mark-downs on the charges based on the submission to encourage every author.
We thank all the support from users and we wish to spread the word “Enliven Archive – Intensifying thoughts” to all your colleagues and people in your track.
PUBLICATION ETHICS:
Journal follows certain publication standards publishing manuscripts. This ensures that we deliver quality research with high standards, develops and retains the trust of authors.
Plagiarism:
Journal checks for plagiarism before peer review process. Upon generation of clear reports, we launch the manuscript process.
Journal rejects manuscripts with high plagiarism scores and does not allow the manuscripts to proceed further for peer review process.
To avoid conflicts, we suggest the authors to submit the plagiarism free content.
Authors may include self-plagiarized content, providing the citations of their previous work.
Authors can resubmit the rejected manuscripts on plagiarism base by carrying out all the corrections and such manuscripts will be considered as new submissions and will undergo the whole process again regardless the stage of the process the article existing before.
Redundant Submissions:
Already published manuscripts and/or manuscripts under process elsewhere are redundant submissions and we reject such submissions from the process immediately. Authors need to look over the publication transfer issues in certain cases else, we reject the manuscript.
Citations Usage:
Manuscripts should avoid the usage of un-wanted citations that improves the quality of articles.
False Data:
Manuscripts should contain original data of experiments, statistics or any entries and authors should not either mimic or plagiarize other manuscripts.
Author Contribution:
Manuscripts should contain the list of authors those who have contributed to the manuscript. Author contribution should contain all authors those who have contributed to the manuscript that may include lab assistants, technicians, and others.
JOURNAL FEATURES:
Copyright Statements: Author gets Open Access Creative Commons License after publishing the work with the journal as we are covered under Creative Commons Attribution 3.0 Unported License. We transfer complete ownership for published content to the author based on this license. This License will permit the reader only to download printout, extract, reuse and distribute the article with appropriate credits to the corresponding author.
Unique Identifiers:
Enliven: Biosimilars and Bioavailability is a member of CrossRef and all the published articles will be assigned with unique article object identifiers (DOIs).
Reprints:
Journal also provides print versions upon the order of authors or any other users with unique citation and by having no change in the published article with minimal reprint charges.
